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1. Introduction  
The definition of sputum is not equivalent to mucus, but sometime clinicians use both 
interchangeably. The definition includes the pathological secretion dispelled by cilia and 
expectorated with coughing. It maintains airway hydration and traps particulates, bacteria, 
and viruses.  
The contents of sputum comprise damaged ciliated epithelium and inflammatory cells. 
Airway mucus possesses antioxidant, antiprotease, and antimicrobial activities. Its volume 
is increased during chronic airway inflammation. The sputum composition can be altered by 
the underlying disease and its severity. The expansion of sputum neutrophil is variably in 
severe asthma or in chronic obstructive pulmonary disease (COPD).  
Cough and ciliary clearance greatly depend on the viscosity of the secretion to the ciliary 
surface (Voynow & Rubin 2009). Surface tension and surfactant interactions can overpower 
surface forces. Tenacity or adhesivity is the greatest determinant for the efficiency of cough 
to eliminate secretion (Voynow & Rubin 2009).  
Sputum analysis is a non-invasive approach to dissect underlying pathophysiology of 
inflammatory airway diseases. The cellular and biochemical constituent of sputum 
correlates well with both bronchial wash (BW) and bronchoalveolar lavage (BAL), but to a 
lesser degree with bronchial biopsies (Fahy, et al. 1995, Pizzichini, et al. 1998, Maestrelli, et 
al. 1995). These observations imply the differences in the luminal and mucosal phase of 
airway inflammation. The fraction of neutrophils decreases from central (20-30%) to 
peripheral airways (<2%) while the opposite is true for macrophages (Rankin, et al. 1992). 
Based on this observation, sputum represents the more proximal airway, whereas BW and 
BAL represent the more peripheral airways. Successive sputum collection after a single 
sputum induction exhibited a stepwise neutrophil decrement and macrophage increment 
(Holz, et al. 1998a, Richter, et al. 1999) reflecting the sampling of more distal airway from 
later collection. The standardization of sputum induction is required to reduce inter- and 
intra-subject variability.  
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2. Sputum induction  
The sputum induction technique allows the noninvasive collection of the airway content 
and provides an opportunity to identify biomarkers of airway inflammation in several 
conditions (e.g., asthma and COPD). It is superior to spontaneous sputum expectoration in 
the higher quantity of collected secretion from the lower airways. Sputum induction 
requires a high degree of cooperation from the patient. The procedure should be performed 
in a quiet environment and conducted by an experienced technician under the supervision 
of an experienced physician.  
Ultrasonic neubulizers are recommended for sputum induction since other nebulizers do 
not provide the sufficient output of saline aerosol. The output of nebulizers should be 
accurately tested. A spirometry provides real-time assessment of the baseline airway caliber 
and promptly alerts for the excessive bronchoconstriction during the saline induction 
(Paggiaro, et al. 2002). A spirometer is superior to a peak flow meter since it provides 
greater sensitivity to measure the decline in force expiratory volume in one second (FEV1) 
that alludes to saline-induced bronchoconstriction. Oxygen saturation should be monitored 
if there is any suspicion of resting hypoxemia. Oxygen supplement should be in reach for 
COPD patients with hypoxemia exacerbation (Paggiaro et al. 2002).  
Sterile saline solution should be freshly prepared. Rescuing medications, bronchodilator 
(inhaled or nebulized salbutamol or other β2-agonists) (Paggiaro et al. 2002) and other 
resuscitation medicines must be nearby. Sputum induction should be performed under 
aseptic environment. Hypertonic saline can induce bronchoconstriction in asthmatics (Smith 
& Anderson 1989) with unknown mechanism, possibly through the activation of mast cells 
(Gravelyn, et al. 1988) or sensory nerve endings (Makker & Holgate 1993).  
The pretreatment with a short-acting β2-agonists is recommended as the standard protocol 
to prevent excessive bronchoconstriction (Pin, et al. 1992, Wong & Fahy 1997, Jatakanon, et 
al. 1998) that could pose asthmatics at risk of an exacerbation. Excessive bronchoconstriction 
might bring about the premature termination of the induction resulting in an inadequate 
sputum collection. Salbutamol (200-400 μg or 2-4 puffs from a metered dose inhaler) can be 
used for pretreatment. Pretreatment with higher doses of salbutamol cannot provide 
additional advantage for the prevention of hypertonic saline-induced bronchoconstriction 
(Wong & Fahy 1997, Cianchetti, et al. 1999, de la Fuente, et al. 1998, Peleman, et al. 1999), but 
may induce more severe subsequent bronchoconstriction. Therefore, a single dose of 
salbutamol 200 μg is recommended both before and after the measurement of FEV1 for 10 
min. Salbutamol pretreatment does not interfere the inflammatory cell percentage in 
induced sputum (Cianchetti et al. 1999, Popov, et al. 1995). Regarding the effects on soluble 
mediators in sputum supernatant, salbutamol has no effect on eosinophil cationic protein 
(ECP) levels, but tends to reduce histamine concentrations (Cianchetti et al. 1999). There has 
been no study for the effect of salbutamol on the levels of other soluble mediators (i.e., 
cytokines, albumin, and neutrophil elastase) or the expression of cell activation markers as 
detected by immunocytochemistry. Also, the data on the comparison between different 
bronchodilators (β2-agonists and anticholinergic drugs) are not available.  
Monitoring pulmonary function during sputum induction is indispensable for safety 
precaution. However, no standardized monitoring protocol for pulmonary function has 
been recommended. Most studies measure FEV1 every 5-10 min, with additional 
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measurement if any symptom develops (Iredale, et al. 1994, Bacci, et al. 1998, Pin et al. 1992, 
Jatakanon et al. 1998, Wong & Fahy 1997, Maestrelli, et al. 1994). Since poor perception of 
dyspnea can exist while bronchospasm can occur early, the measurement of pulmonary 
function within the first minute of nebulization should be performed to identify 
supersensitive subjects. FEV1 should be periodically monitored with an interval of ≤ 5 min 
during aerosol inhalation. A single measurement is appropriate if the change in FEV1 is < 
10% of the postbronchodilator FEV1 value.  
2.1 Selecting saline concentrations  
The concentrations of saline solution for sputum induction varied from 0.9% to 7% in 
different studies. Some investigators raised the concentration in a stepwise manner (3%, 4% 
and 5%) during sputum induction. Saline concentration and nebulizer output might 
influence the safety, tolerability and success rate of the induction as well as the cellular and 
biochemical constituents. The 3% hypertonic saline achieved the same success rate as 3-5% 
given sequentially. Hypertonic saline solutions are more effective than isotonic saline for 
sputum induction. The latter should be reserved for patients at high risk of 
bronchoconstriction. There is a consensus to advocate sputum induction with 4.5% sodium 
chloride solution that is commercially available.  
Hypertonic or isotonic saline did not elicit any significant alteration in cellular ratio or their 
quantity in the sputum. However, the concentration-effect relationship between different 
saline concentrations and the levels of most soluble mediators in the sputum supernatants 
remain unknown. There is no difference in the levels of ECP and histamine in the sputum 
supernatant induced by isotonic or hypertonic saline (Bacci, et al. 1999). Sputum 
supernatant osmolarity fluctuates between 70-360 mOsm as a result of the natively high 
variation in sputum concentrations of sodium, chloride and magnesium from individual 
subjects.  
2.2 Selecting nebulizer  
The selection of nebulizer based on type and output is important for the attainment of 
sputum induction. The ultrasonic nebulizer offers higher success rates than does jet 
nebulizer (Popov et al. 1995). The exact volume of inhaled saline solution that might be 
required to induce an adequate sputum sample is still unclear. The optimal duration of 
inhalation and the optimal output are also unclear. Longer duration might yield samples 
from more distal airways. Other factors include the size of aerosols and their deposited 
locations. The deposition at different locations might yield different sputum composition 
and success rates. The common practice employing ultrasonic nebulizer with an output of ~ 
1 mL/min can achieve a satisfactory quantity.  
2.3 Duration of nebulization  
Duration of nebulization can influence the cellular components of the resulting sputum. At 
the early phase (0-4 min), neutrophils, eosinophils and mucin are major components in the 
sputum. At the later phase (16-20 min), lymphocytes, macrophages and surfactant are 
increasingly noticeable (Holz et al. 1998a, Gershman, et al. 1999). This pattern suggests that 
central airways are sampled at the early phase, whereas peripheral airways and alveoli are 
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sampled at the later phase. The early-phase sputum may be discarded to avoid the saliva 
contamination. Subsequent samples may be more suitable for the analysis. Although the 
maximal duration of induction has not been properly studied, it depends on the conciliation 
between the success rate and the tolerability/safety. Shorter inhalation times (e.g. 15-20 min) 
have similar success rates and practicability to longer inhalation times (30 min). It is critical 
to keep the duration of inhalation constant between inductions in the same subject to obtain 
comparable results. Common practice employs a cumulative duration of nebulization for 15-
20 min. Other influencing factors might include the respiratory frequency during 
nebulization and the patterns of inhalation (i.e., slow deep inhalation or tidal breathing) 
during the challenge.  
2.4 Variations of expectoration  
Some investigators recommend that subjects clean their oral cavity with gargle, dry with 
napkin, spit for saliva, and finally cough for sputum. Others argue that mouth rinsing and 
drying may increase oropharyngeal inflammation. Some authors encourage the use of nose 
clips. Sputum induction protocols are different with respect to the schedule of sputum 
collection. Subjects may be asked to stop inhalation at regular intervals to cough up sputum 
(e.g., every 5 min), or to stop only when they feel the urge to cough. Some protocols require 
subjects to spit saliva into one container before coughing sputum into the other. Spitting 
saliva before coughing sputum decreases the percentage of squamous cells in sputum by 
30% and increases ECP in the supernatant by 80% (Gershman, et al. 1996). The production of 
a good sputum sample relies heavily on the characteristics of the individual subject rather 
than the technical factors.  
2.5 Repeating sputum induction  
Repeated sputum induction can heighten airway inflammation resulting in an iatrogenic 
change in cellular components. Repeating sputum induction at 8-24 h after the initial 
induction can increase neutrophil recruitment in the second sputum sample (Nightingale, et 
al. 1998, Holz, et al. 1998b). An interval of 48 h between two inductions gave comparable cell 
counts in normal subjects (Purokivi, et al. 2000). It is currently recommended that 
subsequent induction should be conducted at least 2 days apart.  
2.6 Sputum induction protocols  
2.6.1 Classical procedure  
1. The detailed information should be provided to the patient prior to the procedure.  
2. All equipments including the ultrasonic nebulizer should be checked for safety and 
calibrated for the output of ~ 1 mL/min. 
3. The baseline FEV1 is measured prior to the bronchodilator inhalation. 
4. The bronchodilator (200 μg salbutamol) is inhaled before the commencement of sputum 
induction.  
5. The FEV1 is measured after the bronchodilator inhalation for 10 min.  
6. Either a fixed concentration (3 or 4.5%) or increasing gradient (3, 4 and 5%) of sterile  
saline is nebulized as an inducer. Each nebulization lasts 5 min follows by a brief  
expectoration. The total duration will last ≤ 20 min. Alternatively, the continuous 20-
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min nebulization may be interrupted at 1, 4, 5, 10, 15, and 20 min for expectoration. The 
subjects will be allowed to spit outside the schedule whenever they develop the urge to 
cough.  
7. The FEV1 at each interruption will be measured. The induction will be terminated if 
there is  20% fall in FEV1 from the postbronchodilator value or the symptoms  develop.  
2.6.2 Customized procedure for high-risk subjects  
1. The detailed information should be provided to the patient prior to the procedure.  
2. All equipments including the ultrasonic nebulizer should be checked for safety and 
calibrated for the output of ~ 1 mL/min.  
3. The baseline FEV1 is measured prior to the bronchodilator inhalation. 
4. The bronchodilator (200 μg salbutamol) is inhaled before the commencement of  
sputum induction.  
5. The FEV1 is measured after the bronchodilator inhalation for 10 min.  
6. The 0.9% sterile saline solution will be nebulized with interruptions at 30 sec, 1, and  5 
min for FEV1 measurement as a safety precaution. If this fails to induce sputum,  the 3% 
saline concentration will be nebulized with interruptions at 30 sec, 1, and 2  min for 
FEV1 measurement. If this also fails to induce sputum, the 4.5% saline  concentration 
will be nebulized with interruptions at 30 sec, 1, 2, 4 and 8 min for  FEV1 measurement. 
The induction will be terminated if there is  20% fall in FEV1  from the 
postbronchodilator value or the symptoms develop.  
7. If the subjects cannot produce spontaneous cough, they will be driven to cough and  
spit after 4 and 8 min.  
2.7 General consideration  
1. The protocol should be strictly enforced, especially the inhalation timing.  
2. The induction should not be repeated within 48 h after the first induction.  
3. The safety procedure must be ensured and readily accessible.  
2.8 Validation of sputum  
The outcome of downstream application relies on the quality of sputum. The procurement 
of secretions from the lower respiratory tract (sputum) induced by the inhalation of aerosol 
from hypertonic saline usually is contaminated with saliva. The assessment of sputum 
quality relies on the quantitation of contaminated squamous epithelial cells.  
The collection method has been optimized to improve the induced sputum quality by the 
selection of viscous portion of the specimen that should minimize the contamination with 
squamous epithelial cells (Pizzichini, et al. 1996b). This selective collection could obtain at 
least two-thirds of the viable nonsquamous cells. After DTT treatment, the cellular contents 
of the selectively collected sample would be dispersed and were ready for cytospin 
examination. This selected portion usually held a similar proportion of neutrophils, 
eosinophils and lymphocytes. However, it contained much higher concentrations of the 
fluid-phase ECP than did the whole expectoration. The unaltered cellular proportion 
suggested that the selection for viscous portion did not alter the indices of airway 
inflammation. Normally, saliva contains mainly squamous epithelial cells (99%) but very 
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low levels of ECP (2–90 ng/mL). The selected viscous portion was generally contaminated 
with very little squamous cells (1.2%), whereas the remaining clear portion contained a large 
portion of squamous cells (70%) (Pizzichini et al. 1996b). The lessening squamous cell 
content unmasked the inflammatory cells, resulting in better quality after the cytospins. 
When the squamous contamination was less than 20%, the accuracy of differential cell 
counts was better, as indicated by high inter and intraobserver reproducibility. The 
processing of cytospin is also quicker, especially when 1,000 or so cells were counted for 
more accurate identification of metachromatic cells and lymphocytes, the minority cellular 
contents. Also, the small proportion of squamous cells provides a homogeneous population 
of cells for examination by flow cytometry (Kidney, et al. 1996).  
Alternatively, the quality of induced sputum specimen can be evaluated by the presence of 
high proportion of viable nonsquamous cells. Cell viability is an important requirement for 
accurate cell identification. With greater than 50% viability, the reproducibility of cell counts 
is better. Higher viability also provided an advantage for immunological staining to 
determine subpopulations and activation markers (Hansel, et al. 1991, Kidney et al. 1996, 
Vatrella, et al. 2010).  
In summary, the physical selection of viscous portion from the mixed expectorate has 
several advantages over the whole specimen. It is almost free of squamous cells and is 
therefore essentially undiluted. Cells are in better condition and the concentrations of 
eosinophilic cationic protein are higher. If the expectorate is not processed within 2 h, a 
large error might be introduced. The serous portion, which is rich in squamous cells, could 
be homogeneously mixed with the otherwise desirable viscous portion. The reproducibility 
of cell counts is threatened if squamous cell contamination represents > 20% of all recovered 
cells.  
3. The conventional practice for cytologic study  
The sputum should be processed as soon as possible or within 2 h to ensure optimal cell 
counting and staining (Pizzichini et al. 1996b, Fahy, et al. 1993). The dithiothreitol (DTT) is 
used to split the disulfide bonds in mucin to release the cells (Cleland 1964). Cells anchoring 
to the mucus tend to get dark stain that hinders accurate identification. DTT provides more 
effective cellular liberation from the mucus than does phosphate buffered saline (PBS) and 
has no effect on cell counts.  
The duration and temperature of mixing can vary between 10-30 min and 4-37°C 
respectively. This range of DTT exposure time at room temperature has no effect on the 
differential cell count (Popov, et al. 1994). The mixing of sputum with DTT can be 
performed with either a shaking water bath at 37°C followed by periodic aspirations, or a 
tube rocker at 22°C (Popov et al. 1994, Fahy et al. 1993, Spanevello, et al. 1998). The use of a 
plastic transfer pipette for aspiration and expulsion of sputum is not recommended since it 
decreases cell yield due to incomplete mixing (Popov et al. 1994, Hansel et al. 1991).  
A sample filtration is strongly recommended for removing residual mucus and debris to 
improve slide quality. A single filtration through a 48-μm nylon mesh results in a slight 
reduction in the total cell count but the differential cell count remains unchanged 
(Efthimiadis, et al. 1996, Efthimiadis, et al. 2000). However, little is known about the effect of 
repeated filtrations on differential cell count.  
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Since the total cell count could be lessened after centrifugation (Parameswaran, et al. 2000, 
Rerecich, et al. 1999), it is therefore recommended that total cell count be performed prior to 
centrifugation to exactly obtain the original cell count. The currently automated machine is 
not reliable for determining total cell count and differential cell count, and is still not 
recommended.  
Centrifugation is generally used to separate sputum cells from the fluid phase. The 
centrifugation force should be set between 300 - 1500  g for 5-10 min to obtain adequate 
separation of the cells and the supernatant (Fahy et al. 1993, Louis, et al. 1999, Pizzichini, et 
al. 1996a). The storage temperatures for cells and supernatants are -20°C and -70°C 
respectively (Pizzichini et al. 1996a).  
The optimum cell density for cytospins is 40-60  103 cells / slide that provide a more 
accurate estimate for cell distribution than does the smearing technique (Pizzichini et al. 
1996a, Popov et al. 1994). The centrifugation force of 22  g for 6 min is generally employed 
(Pizzichini et al. 1996a, Popov et al. 1994). Although this speed is below the limits of 
minimal cell distortion, there is a risk of losing lymphocytes at low speeds due to the 
dispersion to the supernatant (Fleury-Feith, et al. 1987, Mordelet-Dambrine, et al. 1984). This 
should be taken into account in the investigations of sputum lymphocytes.  
The differential cell counts can be accomplished using either Wright’s or Giemsa stain 
(Efthimiadis, et al. 2002). The buffers must be titrated to the optimal pH (7.1-7.2) 
(Efthimiadis et al. 2002) to allow accurate characterization of cells based on their optimal 
staining while maintaining original morphology. The differential cell count requires a 
minimum of 400 nonsquamous cells (Efthimiadis et al. 2002). The report should contain the 
relative numbers of eosinophils, neutrophils, macrophages, lymphocytes and bronchial 
epithelial cells expressed as a percentage of total nonsquamous cells. The percentage of 
squamous cells should always be reported separately.  
4. Immunocytochemistry procedures  
The sputum suspension is centrifuged at 300  g for 10 min, resuspended in PBS or Hank’s 
balance saline solution (HBSS). The cytospins are prepared on L-polylysine-coated slides to 
ensure minimal cell loss during multiple washing steps. The attached cells are air-dried for 
10 min and fixed appropriately. After fixation, cytospins should be wrapped in foil and 
stored at -20°C pending for staining.  
The method of fixation is critical and needs to be optimized for any particular antigen to 
obtain the best quality of immunostaining. The selected fixation method should allow the 
proper preservation of antigens / cellular morphology and the penetration of antibodies 
into the entire cells. The fixation regimens may include either 2 or 4% paraformaldehyde, 
formalin, acetone/methanol (60/40) or periodate-lysine-paraformaldehyde (PLP). The latter 
is a fixative for surface glycoprotein staining but may also be used for cytokine staining 
(McLean & Nakane 1974). For instance, PLP fixation provided better morphology of cryostat 
sections but poorer immunostaining than conventional acetone immersion. However, a brief 
acetone fixation followed by PLP fixation offered excellent morphology preservation and 
good quality of immunostaining (Hall, et al. 1987). PLP was proposed for the fixation of 
multiple membrane antigens in skin biopsies (Pieri, et al. 2002). The benefit of PLP fixation is 
in the preservation of cellular ultrastructures (i.e., immunoglobulins) for 
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immunofluorescence or immunoperoxidase staining of paraffin-embedded specimens 
(Rantala, et al. 1985). For marker staining of induced sputum cells, PLP-sucrose provided 
the best results with the highest percentage of CD3+ cells and a better staining quality than 
did the paraformaldehyde and acetone-methanol-fixed cells that provided the worst 
staining of CD68 (St-Laurent, et al. 2006). Simultaneous fixation and permeabilization using 
Ortho PermeaFix for flow cytometry are required for the best identification of intracellular 
antigens (i.e., eosinophil cationic protein, eosinophilic peroxidase, neutrophil 
myeloperoxidase) in cytocentrifuged cells (Metso, et al. 2002). Organic solvents as fixatives 
are not suitable while the crosslinking fixatives (e.g., paraformaldehyde) alone could not 
provide a complete penetration of antibodies into the cell interior (Metso et al. 2002).  
To detect intracellular antigens, sputum cells must be permeabilized after the fixation with 
paraformaldehyde and glutaraldehyde. Permeabilization allows the antibody to gain an 
access to intracellular or intraorganellar antigens. Two common permeabilizing agents are 
organic solvents (i.e., methanol and acetone) and detergents.  
The organic solvents work through dissolving lipids from cell membrane, thereby 
disrupting the membrane and allowing the influx of the antibodies. The ability of the 
organic solvents to coagulate proteins provides an additional advantage of cell fixation. The 
shortcoming of organic solvents is the removal of lipidic antigens or lipid associated 
antigens from cells.  
One of the most commonly used detergents is saponin, a plant glycoside. Saponin 
permeabilizes cells through the removal of cholesterol, thereby puncturing holes over the 
membrane (Seeman, et al. 1973). Saponin can form micelle with antibody and cholesterol 
that facilitates the entry through the punctured holes. However, saponin cannot effectively 
permeabilize mitochondrial membranes and the nuclear envelope due to their low 
composition of cholesterol (Goldenthal, et al. 1985a). Therefore, saponin is suitable for 
immunostaining of intracellular membrane antigens localized over lysosomal membrane, 
plasma membrane, endocytic vesicles and endoplasmic reticulum (Goldenthal, et al. 1985b). 
However, Triton X-100 and NP-40 interfere the staining at these sites (Goldenthal et al. 
1985b).  
Other commonly used detergents are the non-ionic detergents such as Triton X-100 and 
Tween 20 (Maneechotesuwan, et al. 2010, Maneechotesuwan, et al. 2008). They carry 
uncharged, hydrophilic head groups of polyoxyethylene moieties. Antigens localized in 
mitochondria and the nucleus required Triton X-100 for their detection (Goldenthal et al. 
1985b). Their shortcoming is their non-selective nature that could produce a false negative 
during immunostaining through the removal of proteins along with the lipids. A 
combination of different permeabilizing agents may be customized for each antigen 
(Goldenthal et al. 1985a).  
Immunocytochemical staining can be performed with different varieties, including 
avidin/biotin complex, peroxidase/antiperoxidase and alkaline phosphatase / antialkaline 
phosphatase techniques. The use of immunoenzymatic techniques eliminates the need for 
expensive fluorescent microscopy. The alkaline phosphatase / antialkaline phosphatase 
method is preferable. The staining with the monoclonal antibodies on fixed slides should be 
titrated for appropriate concentrations and can be incubated overnight at 4°C. The 
secondary antibodies are then applied and the antibody/antigen complex is visualized 
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using the alkaline-phosphatase-linked substrate, with either fast red or fast blue 
counterstains. Negative controls must always be included to exclude the potential false 
positive staining. The peroxidase staining methods are not recommended for sputum.  
5. Modifications of immunocytochemistry for sputum specimen  
Homogenization with low-concentration DTT (0.5 mM) would liberate the otherwise 
anchored cells from the surrounding mucus that facilitate the exposure of the cells to the 
staining antibodies (Tockman, et al. 1995). However, the use of DTT to disperse cells may 
hamper cellular functions (e.g., the release of elastase and myeloperoxidase (MPO) from 
neutrophils (van Overveld, et al. 2005)) or hinder antigenic epitopes for 
immunocytochemical staining. Some investigators recommended the use of 
paraformaldehyde to fix the sputum cells prior to the treatment with low concentration of 
DTT.  
The method employing avidin-biotin complex (ABC) is suitable for the 
immunocytochemistry of sputum cells (Maneechotesuwan et al. 2008, Maneechotesuwan et 
al. 2010). The biotin / avidin system possesses several advantages to sputum 
immunocytochemistry. 1) The binding affinity of avidin to biotin is higher than that of any 
antibody directing against its epitope. 2) The binding of avidin to biotin is almost 
irreversible. 3) The multiple binding sites on each molecule (four binding sites for biotin on 
each avidin; two binding sites for avidin on each biotin) provide the formation for 
macromolecular complexes between avidin and biotinylated enzymes. The ABC-alkaline 
phosphatase (AP) lattice complex consists of several biotinylated alkaline phosphatase 
molecules cross-linked by avidin. The two biotin molecules can be joined via an avidin 
molecule that eventually forms a complex of avidin and biotinylated enzyme or biotinylated 
secondary antibody. The stoichiometry of the forming complex will contain an available 
biotin binding site on ABC for the binding of the biotinylated secondary antibody. The 
formation of the complex is developed by gradual mixing avidin and biotinylated alkaline 
phosphatase with predefined ratios prior to use. The ABC complex can be stable until 24 h 
after the formation. This technique provides multiple enzymes attaching to the antigenic 
site, thereby enhancing the detection sensitivity. The sensitivity provided by this method is 
generally higher than that obtained with the conventional peroxidase-anti-peroxidase (PAP) 
technique. However the size of the ABC complex can be inappropriately high that it 
sterically interferes the overall binding, resulting in decreasing the resolution.  
The ABC method can also be modified to incorporate different enzymes that provide 
different chromogenic properties (Bratthauer 2010). These enzymes include alkaline 
phosphatase (AP). The high sensitivity of the ABC-AP system permits the detection of the 
small amount of antigen using higher dilution of a primary antibody. Therefore, the ABCAP 
system is recommended for staining situation in which high sensitivity is a prerequisite such 
as sputum immunocytochemistry. The advantages of these techniques lie in the availability 
of suitable secondary agents. The shortcoming of this system is the presence of endogenous 
alkaline phosphatase, which is more ubiquitous than endogenous peroxidase and is tougher 
to remove. However, the alkaline phosphatase can generate more color producing 
molecules per enzyme molecule than can peroxidase, resulting in higher sensitivity. 
Endogenous alkaline phosphatase can be partially blocked by incubation with 3 mM 
levamisole for 15 min with some remaining residual activity.  
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Labeling of 2 epitopes can employ the simultaneous peroxidase and AP methods. An ABC 
assay system can be applied to the detection of more than one antibody on an individual 
specimen. In double labeling, experiments having two completely different assay systems 
would minimize the cross-over reactivity. The first antigen can be detected with the 
standard ABC procedure, while the second antigen can be detected using the PAP system. 
The two techniques provide minimal cross-over reactivity, especially if alkaline phosphatase 
is employed along with the peroxidase enzyme (Gillitzer, et al. 1990).  
Various sugar moieties interfere with the binding of streptavidin or avidin to biotin. The 
most effective inhibitory sugar is mannose, followed by other saccharides. The inhibitory 
action probably involves the interactions of the sugars with reactive residues at the binding 
sites (Houen & Hansen 1997).  
6. Practical considerations  
1. Commercial PBS or TBS are recommended to maximize the reproducibility. The buffer 
should be prepared according to the manufacturer’s recommendations. The commercial 
buffer usually makes up 5 L of solution.  
2. The primary antibody should be diluted with TBS or PBS to an optimal concentration. 
These should be empirically titrated on a known positive specimen. Working antibody 
concentrations usually lie between 10-20 g/mL. Depending on the individual reagent, 
this concentration could vary considerably. The initial dilution can start at 1:10 with 
subsequent serial 1:10 dilutions, resulting in 10, 100, 1000, and 10,000-fold dilutions of 
the original antibody. Optimal staining can be obtained from this wide range of 
dilutions. A higher resolution for the optimal staining can be obtained through serial 1:2 
dilutions of the formerly obtained wide dilution. The antibodies can be aliquoted and 
stored in concentrated form at -70 to –80°C indefinitely. The antibodies should be 
thawed once and used immediately. Refreezing antibodies should be avoided. 
However, the manufacturer recommends that the ABC reagent components should be 
stored at 4°C. The antibody can be thawed and diluted to a concentrated stock solution 
from which more diluted working solutions can be prepared. These stock solutions can 
be kept at 4-8°C for a week.  
3. An antibody in either polyclonal or monoclonal format can be applied for sputum 
staining with distinct advantages / disadvantages. The polyclonal antibody generally 
provides strong signal with reasonably good specificity, but can generate some 
background noise. The signal strength of a monoclonal antibody depends on its 
qualities and affinity but its specificity for antigen binding is far better than that of the 
polyclonal format. The preference for a monoclonal antibody over a polyclonal 
antibody largely depends on the availability of a qualified antibody with matching 
application. The chosen antibody has to be specific with no cross reaction to other cell 
components. The antibody should contain a high affinity to the antigen be produced in 
high titer. The monoclonal antibody generally creates minimal background noise. Its 
high affinity can withstand multiple processing steps of staining and washing with 
minimal loss of the attaching antibody.  
4. The incubation with 10% xenogeneic serum will mask all non-specific binding sites on 
the specimen. The 10-min incubation with the 10% xenogeneic serum can prevent the 
non-specific antibody binding. The proportion of the serum and the incubation time can 
be optimized to generate acceptable signal.  
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5. The choice of blocking serum depends on the originating species of the secondary 
antibody. A universal type of blocking serum can be used if the secondary antibody has 
multiple host species to avoid the cross-reactivity. The pooled or universal secondary 
antibody can be used regardless of the originating species of the primary antibody. 
Proteins from other sources (e.g., milk, or casein-based solutions) can be employed as 
blocking agents, but they may not produce better results.  
6. The specimens should be kept hydrated throughout the staining procedure. The 
inadvertent drying can generate nonspecific antibody binding. A chamber rack can be 
used to prevent the flowing of antibodies away with gravity.  
7. All reagents and slides should sit at room temperature before the staining. The 
antibodies should be fully dissolved or reconstituted. The staining results can even be 
better if the antibody solutions are prepared the day before and left at 4°C overnight. 
The incubation time and temperature can be raised to optimize the reactivity. However, 
this might increase the background noise too. The reaction may be slightly improved 
without cumulative background by the incubation with primary antibody overnight at 
4°C (Clements & Beitz 1985).  
8. Vigorous rinsing is recommended to lessen the background noise. However, direct 
splashing to the specimen surface with the wash stream may dislodge antibodies with 
low affinity. The stream should be rapidly running from one end of the slide, crossing 
the slide surface to the other end. The washing step is the most critical factor to lessen 
the background noise and could be extended if the background noise is heavily 
concerned. The inclusion of non-ionic detergent (i.e., 0.25% Triton X-100 or 0.1% 
Tween 20) may also lessen the background (Laitinen, et al. 1983, Maneechotesuwan et 
al. 2008). However, these detergents may interfere the charge interactions of 
antibody-antigen binding, resulting in decreasing reactivity. These detergents should 
be applied to poly-L-lysine-coated or charged slides to improve the hydrophobicity of 
these slides. The reaction can be strengthened through extending incubation times (60 
min for primary and 45 min for the secondary or ABC incubation), raising chromogen 
concentration to prevail over the dampening effect of the detergents. The chromogen 
concentration may be raised from 2-5 times. If background noise is highly concerned, 
a preabsorption of the slide with blocking agents may be required. The antibody may 
be diluted in buffer containing 2% bovine serum albumin, or secondary species serum 
to avoid the reaction from contaminating non-specific antibodies against a serum-
based constituent.  
9. The formation of ABC complex takes at least 30 min to be stable. Only after the ABC 
complex is stably formed can the secondary antibody be added. The complex can be 
kept in the refrigerator for at least 72 h. 
10. The counterstain should not be stronger than the principal reaction; otherwise the 
staining sites can be masked by darker counterstain. 
11. Many substrates for alkaline phosphatase provide permanent straining with different 
color. A combination of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and nitro blue 
tetrazolium (NBT) yield permanent blue precipitates at the site of alkaline phosphatase, 
while the Fast Red TR/Naphthol AS-MX yields a permanent red precipitates.  
12. The staining sensitivity can be increased through the use of multiple chromogens and 
multiple enzymes targeting numerous antigens. More substrate precipitation or greater 
color resolution improves the sensitivity.  
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Fig. 1. The sputum cells were immunocytochemically stained for indoleamine 2, 3 
dioxygenase with VECTOR® ABC-AP KIT. 
  
Fig. 2. The sputum cells were immunocytochemically stained for interleukin-10 with 
VECTOR® ABC-AP KIT.  
6.1 Prototypic procedure for immunocytochemical staining of a sputum specimen 
(VECTASTAIN® ABC-AP KIT) 
1. The cytospin slide will be removed from the freezer (-20°C) and left at room 
temperature for 30-60 min. 
2. The cellular spot on the slides will be encircled with the wax pen.  
3. The slide will be washed once with PBS for 5 min.  
4. The washed slide will be placed horizontally in a humidified chamber. 
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5. The sputum cells will be fixed with 2% paraformaldehyde (PFA) for 5 min. 
6. The slide will be completely washed once with PBS to remove residual PFA for 5 min. 
7. The cell membrane will be permeabilized with 0.5% NP-40 diluted in PBS for 10 min. 
8. The slide will be washed once with PBS for 5 min.  
9. Nonspecific binding will be blocked with the blocking serum (normal serum) from the 
Vector Kit (3 drops of stock to 10 mL PBS with 0.05% tween-20) for 30 min. 
10. The slide will be incubated with the primary antibody pre-diluted in PBS with 0.05% 
tween-20 (1:100) for 1 h. 
11. The slide will be washed thrice with PBS containing 0.05% tween-20 for 5 min. 
12. Incubate the slide with the biotinylated secondary antibody pre-diluted in PBS with 
0.05% tween-20 (add 1 drop of stock to 10 mL PBS with 0.05% tween-20) for 45 min. 
13. The VECTASTAIN® ABC-AP Reagent will be prepared by adding exactly 2 drops of 
Reagent A to 10 mL PBS with 0.05% tween-20, followed by adding 2 drops of Reagent 
B. The mixture will be immediately mixed and left at room temperature for at least 30 
min before the next step. 
14. The slide will be washed thrice with PBS containing 0.05% tween-20 for 5 min each. 
15. The slide will be incubated with VECTASTAIN® ABC-AP Reagent for 30 min. 
16. The slide will be washed once with PBS without tween-20 for 5 min.  
17. The Vector® Red substrate working solution will be prepared immediately before use 
in test tube by adding 2 drops of Reagent 1 to 5 mL 100 mM Tris-HCl (pH 8.2-8.5) 
followed by a thoroughly mixing. The mixture will be subsequently reconstituted with 
2 drops of Reagent 2 and 2 drops of Reagent 3 sequentially with a thoroughly mixing 
after each reagent addition.  
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discussed. Applications of Immunocytochemistry offers technical and background information on different
steps of immunocytochemistry and presents the application of this technique and its adaptations in cell lines,
neural tissue, pancreatic tissue, sputum cells, sperm cells, preimplantation embryo, arabidopsis, fish gonads,
and Leishmania.
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